L326-0045 Screening compound: 1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide

L326-0045 Screening compound: 1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide
L326-0045 Screening compound: 1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L326-0045
1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L326-0045

Molecular Formula

C27H31N5O2 (C27 H31 N5 O2)

Compound Name

1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide

IUPAC name

1-[5-(3-methylphenyl)pyrimidin-2-yl]-N-[4-(morpholin-4-yl)phenyl]piperidine-4-carboxamide

SMILES

Cc1cccc(-c2cnc(N(CC3)CCC3C(Nc(cc3)ccc3N3CCOCC3)=O)nc2)c1

InChI

InChI=1S/C27H31N5O2/c1-20-3-2-4-22(17-20)23-18-28-27(29-19-23)32-11-9-21(10-12-32)26(33)30-24-5-7-25(8-6-24)31-13-15-34-16-14-31/h2-8,17-19,21H,9-16H2,1H3,(H,30,33)

InChI Key

XYRUQQNWIGVXPK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27245540

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.797

Distribution Coefficient, logD

3.797

Water Solubility, LogSw

-3.64

Polar Surface Area

56.413

Acid Dissociation Constant (pKa)

11.90

Base Dissociation Constant (pKb)

6.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

L326-0045 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L326-0045 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L326-0045?
Check Price and Availability of L326-0045, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L326-0045 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L326-0045
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L326-0045
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L326-0045 available by request